Global Coalition on Aging Calls on Governments, Health Systems, Employers, and Other Stakeholders to Prioritize Action on Eye Health

New paper challenges prevailing view that vision loss is a normal consequence of aging and warns about the fiscal unsustainability of inaction.

(New York –May 2, 2019) – Today, the Global Coalition on Aging (GCOA) released a new white paper, titled A Life Course of Healthy Vision: A Critical Priority for the 21st Century, which upends the prevailing view of deteriorating vision as an inevitable consequence of aging and examines the health and economic impacts of visual impairment and vision loss. The paper calls on policymakers, health systems, employers, and advocates alike to prioritize action to reduce the global burden of visual impairment and vision loss.

“For far too long, deteriorating vision has been accepted as simply a normal part of growing older,” said Michael W. Hodin, PhD, CEO of GCOA. “While we know that the vast majority of vision loss is among those over 50 – the fastest growing demographic group, globally – we also know that a full 80% of declining vision is avoidable with appropriate eye care, prevention, early intervention, and treatment. Because of the devastating impact of vision loss on functional ability, independence, quality of life, worker productivity, and, therefore, economic growth, government and employers alike must recognize the urgent need to interrupt our current trajectory. Failure to do so will be fiscally unsustainable for us all.”

In 2017, there were 253 million people worldwide who were considered visually impaired. This number is expected to more than double to 587.6 million by 2050, and the number of those with vision loss is expected to triple in this same time period. Visual impairment and vision loss are uniquely expensive, above and beyond the costs of direct medical care, as a result of the loss of independence that often follows. By next year, the indirect costs of visual impairment are expected to total $760 billion, largely due to increased care needs and lost productivity.

“Visual impairment and vision loss are devastating for the individual, who may no longer be able to work or to live independently and may now be at greater risk for depression, Alzheimer’s, and falls, among other health challenges,” said Dr. James Tsai, President of New York Eye and Ear Infirmary of Mount Sinai. “And because of the important connection between eye health and the rest of the body, expanding our capacity to provide eye care can also yield important advances in our ability to diagnose and manage other health conditions, including neurological diseases, hypertension, and diabetes. Prioritizing vision on the health and economic policy agendas has the potential to yield exponential benefits.”

The white paper is based on insights from GCOA’s December 2018 Life Course of Healthy Vision roundtable, which brought together experts and advocates from the fields of eye health, aging, healthcare, business, technology, and academia. The paper identifies barriers to adequate eye care, including ageism, health system silos,treatment burden, strained capacity, and policy,and calls for immediate action across five key pillars:

  • Access and Capacity: Health systems must develop strategies to increase access to regular eye care and necessary treatments as well as increase the capacity of professionals across the care ecosystem to provide screening, prevention, and specialty care.
  • Financing: Policymakers must ensure that funding mechanisms support and incentivize wider access to high-quality eye care.
  • Research: To address the growing burden of visual impairment and vision loss, we must enable ongoing innovation in treatments, technologies, and interventions.
  • Education:Increasing literacy about basic eye health and the close connection between eye health and other health conditions are critical for both healthcare professionals and the public.
  • Workplace:Employers have an important opportunity and an interest in supporting eye health through wellness and screening initiatives, ensuring that our workforces remain healthy and productive at every age.

As momentum builds in preparation for the World Health Organization Decade of Healthy Ageing (2020-2030), member states, employers, and stakeholders around the world have a critical window of opportunity to recognize that healthy vision is an indispensable and underrecognized component of healthy aging and to commit to actions that prioritize a life course of healthy vision for all.

To read the full report, click here.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.